Sen H. Zhuang - 28 Janssen Research and Development

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table 1 from A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors

Josep Tabernero,Luc Dirix,Patrick Schöffski,Andrés Cervantes, Jose Antonio Lopez-Martin,Jaume Capdevila,Ludy van Beijsterveldt,Suso Platero,Brett Hall,Zhilong Yuan,Roland Knoblauch,Sen Hong Zhuang

openalex（2023）

引用0浏览0引用

Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up

Jian-Qing Mi,Wanhong Zhao,Hongmei Jing,Weijun Fu,Jianda Hu,Lijuan Chen,Yiwen Zhang,Dan Yao, Hui Li,Jordan M. Schecter, Fan Yang,Huabin Sun,Sen Hong Zhuang, Da Xu, Tracy Luo,Xiaohu Fan,Ting Niu,Jie Jin,Sai-Juan Chen

Blood（2022）

引用3浏览0引用

Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed And/or Refractory Multiple Myeloma (R/R MM)

Deepu Madduri,Saad Z. Usmani,Sundar Jagannath,Indrajeet Singh,Enrique Zudaire,Tzu-Min Yeh,Alicia J. Allred,Arnob Banerjee,Jenna D. Goldberg,Jordan M. Schecter,Sen Zhuang,Jeffrey R. Infante,Syed Rizvi,Xiaohu (Frank) Fan,Andrzej Jakubowiak,Jesus G. Berdeja

Blood（2019）

引用111浏览0引用

111

A Phase Iii Study of Ibrutinib in Combination with Either Bendamustine and Rituximab (br) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-Chop) in Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma

Nathan Hale Fowler,Wolfgang Hiddemann,John Leonard,Julie S. Larsen,Esther Rose,Sen Hong Zhuang,Jessica Vermeulen,Steven Sun, Lisa Mentzer,Tzu-Min Yeh,Gilles A. Salles

Journal of Clinical Oncologyno. 15_suppl (2015): TPS8601-TPS8601

引用5浏览0引用

Development of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib for B Cell Malignancies

Urte Gayko, Mann Fung,Fong Clow,Steven Sun, Elizabeth Faust, Samiyeh Price,Danelle James,Margaret Doyle, Samina Bari,Sen Hong Zhuang

Annals of the New York Academy of Sciences（2015）

引用38浏览0WOS引用

A randomized, double blind, placebo controlled phase 3 study of ibrutinib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R CHOP) in …

Anas Younes,Pier Luigi Zinzani,Laurie Helen Sehn,Peter WM Johnson,Randy D Gascoyne,Tahamtan Ahmadi,Kevin M Bellew,Jessica Vermeulen,Sen Hong Zhuang,Steven Sun,Louis M Staudt,Wyndham Hopkins Wilson

user-5ebe28d54c775eda72abcdf7（2014）

引用15浏览0引用

The HELIOS Trial Protocol: a Phase III Study of Ibrutinib in Combination with Bendamustine and Rituximab in Relapsed/refractory Chronic Lymphocytic Leukemia

Michael Hallek,Neil E. Kay,Anders Osterborg,Asher A. Chanan-Khan,Michelle Mahler,Mariya Salman,Ying Wan,Steven Sun,Sen Hong Zhuang,Angela Howes

Future Oncology（2014）

引用22浏览0WOS引用

Mutational Analysis of Patients with Primary Resistance to Single-Agent Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Sriram Balasubramanian,Michael Schaffer,William Deraedt,Cuc Davis,Emily Stepanchick,Regina Aquino,Zhilong Yuan,Britte Kranenburg,Irit Avivi,Martin Dreyling,Simon Rule,Michael Wang,Sen Hong Zhuang,Aleksandra Rizo,Georg Lenz

Blood（2014）

引用32浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn